Dramamine and breastfeeding: what the lactation database actually says

You are probably reading this late, on a phone, with a drive in the morning and a box of Dramamine in a drawer. The results you scrolled past are mostly parenting blogs quoting each other.

The database they are paraphrasing is public, free, and written for nursing mothers as much as for health professionals. Here is what it says about dimenhydrinate, meclizine and milk supply. What it will not do is say yes or no. That part is a short conversation with a pharmacist.

Ask your doctor or pharmacist, then read this

A pharmacist can usually answer this at the counter, with no appointment. They will ask for details a webpage cannot know: your baby's age, whether they were born early, whether your supply is established or still settling, what else you take, and whether you face one car journey or ten days at sea. Those details are most of the answer. The record below is only their starting point, and almost nobody publishing on this question quotes it.

What LactMed records for dimenhydrinate

LactMed is the National Library of Medicine's drugs and lactation database. It is free, every statement in it is referenced to the published literature, and a peer review panel checks the entries. It is written for breastfeeding mothers and health professionals alike, so you can read the same page your pharmacist reads.

The dimenhydrinate record, last revised in September 2021, opens with the reassuring half: small, occasional doses would not be expected to cause any adverse effects in breastfed infants. The next sentence gets left out. Larger doses or more prolonged use may cause effects in the infant or decrease the milk supply, particularly in combination with a sympathomimetic such as pseudoephedrine, or before lactation is well established.

Three details from the same record are worth carrying with you:

• The measured data is thin, and the record says so. For levels in milk it cites one old study that used a biologic assay after an injected dose of diphenhydramine, then states plainly that no studies using modern assay methods have been reported. For levels in the infant, relevant published information was not found.
• The reported infant effects come from a study of antihistamines in general. In one telephone follow-up study, mothers reported irritability and colicky symptoms in 10% of infants exposed to various antihistamines, and drowsiness in 1.6%. The record adds that none of the reactions required medical attention.
• The record names an alternate. Under alternate drugs to consider, it lists meclizine.

The box says it in one line. The Dramamine Original Formula label, dimenhydrinate 50 mg, carries the standard warning: if pregnant or breast-feeding, ask a doctor before use. Our page on dimenhydrinate covers the drug in general.

The question underneath the question: milk supply

Most people searching this are not really asking whether one tablet will harm the baby. They are asking whether it will cost them their supply. The record does address that, and the wording matters: larger doses or more prolonged use may decrease the milk supply. That is a flagged risk, not a measured drop, and two conditions sharpen it. One is combination with a sympathomimetic such as pseudoephedrine, worth checking for on any multi-symptom cold box. The other is use before lactation is well established, which puts the early weeks in their own category.

The mechanism the database points at is prolactin. Both records carry the same note, including the meclizine record: antihistamines given by injection in relatively high doses can lower basal serum prolactin in nonlactating women and in women who are newly postpartum, while the prolactin released in response to suckling is not affected when mothers are given an antihistamine beforehand. Whether ordinary oral doses do anything to prolactin has not been studied.

So it is a caution with a gap behind it. If supply is your real worry, say so to a pharmacist or a lactation consultant.

Meclizine, and why it is often the one people are told to ask about

Dramamine is a brand, not a drug. Original Formula is dimenhydrinate. Less Drowsy is meclizine. So is Bonine, which comes as 25 mg chewable tablets. Ask about the wrong one and you get an answer about the wrong molecule, so bring the box.

LactMed's meclizine record was revised in April 2026, more recently than the dimenhydrinate one. It says occasional doses are probably acceptable during breastfeeding, then repeats the caution about large doses, prolonged use, sympathomimetics and lactation that is not yet established. It also says no relevant published information on meclizine levels in milk, maternal or infant, was found. Probably acceptable is a judgement from the drug class, not from measurements.

The Bonine label ends where the Dramamine one does: if pregnant or breast-feeding, ask a health professional before use. Our page on meclizine has the general picture.

The scopolamine patch is a separate conversation

The patch worn behind the ear is scopolamine, and it is prescription-only in the US. That settles where the breastfeeding question gets answered: at the moment of prescribing.

The prescribing information states that scopolamine is present in human milk, and that there are no available data on the effects on the breastfed infant or on milk production. It asks that the developmental and health benefits of breastfeeding be considered along with the mother's clinical need for the patch. One patch is worn for up to three days, so it commits you for longer than a tablet does. Never borrow one from a travel companion's kit. Our page on the scopolamine patch covers what it is used for.

Timing around a feed

LactMed's dimenhydrinate record includes one note about timing, and it is the sentence most worth bringing to your pharmacist: single bedtime doses after the last feeding of the day may be adequate for many women and will minimize any effects of the drug.

Read that as the record's observation, not as instruction from this page. Whether to take anything at all, how much, and when is your clinician's call. If you are wondering whether to discard milk afterwards, ask them directly rather than acting on a rule you found online.

Options that do not involve a tablet

Worth doing whatever you decide about medicine:

• Seat and gaze. Front seat if you are a passenger, eyes on the road far ahead, phone down. Settling a baby in a moving back seat puts your head down and your eyes on something still, which is the posture most likely to bring car sickness on. Plan a stop instead.
• Air and food. Cool air on your face, small bland snacks so your stomach is never empty, water in reach.
• Stops before you need them. Queasiness is easier to head off than to reverse.
• Drug-free options, compared honestly. Bands, ginger and the rest are covered one by one in our drug-free comparison, including where the evidence is weak. The practical playbook is in how to stop motion sickness.
• One disclosure. This site is run by the makers of Dizzout, a drug-free sound therapy app that plays precisely calibrated audio through any headphones. It is one option among the ones above. Mention it to your clinician the way you would mention any of them.

What to watch for in the baby

If you and your clinician decide to go ahead, the effects reported in the antihistamine follow-up study LactMed cites are the ones to watch: unusual drowsiness, irritability, and colicky symptoms. Call your doctor or pharmacist if you see them. Ask sooner rather than later if your baby is a newborn or your supply is still settling, since the record's own caution about lactation that is not yet established points at that window.

One last piece of sorting. Breastfeeding and pregnancy are different questions, and the answers do not transfer. If you are pregnant rather than nursing, start on our pregnancy page, or with can you take Dramamine while pregnant and pregnancy-safe remedies.

Frequently asked questions